The lipid phosphatase Synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer’s disease
Ando, Kunie, Ndjim, Marième, Turbant, Sabrina, Fontaine, Gaëlle, Pregoni, Gustavo, Dauphinot, Luce, Yilmaz, Zehra, Suain, Valérie, Mansour, Salwa, Authelet, Michèle, De Dekker, Robert, Leroy, Karelle, Delatour, Benoît, Letournel, Franck, Martin-Négrier, Marie-Laure, Chapon, Françoise, Godfraind, Catherine, Maurage, Claude-Alain, Deramecourt, Vincent, Meyronnet, David, Streichenberger, Nathalie, de Paula, André Maues, Rigau, Valérie, Vandenbos-Burel, Fanny, Duyckaerts, Charles, Seilhean, Danielle, Boluda, Susana, Plu, Isabelle, Milin, Serge, Chiforeanu, Dan Christian, Laquerrière, Annie, Lannes, Béatrice, Potier, Marie-Claude, Brion, Jean-Pierre
Published in Acta neuropathologica communications (03.06.2020)
Published in Acta neuropathologica communications (03.06.2020)
Get full text
Journal Article
The presynaptic lipid phosphatase Synaptojanin1 shows increased insolubility in Alzheimer brains, is localized with Hirano bodies and accumulated in plaque-associated dystrophic neurites
Ando, Kunie, Ndjim, Marième, Pregoni, Gustavo, Dauphinot, Luce, Fontaine, Gaëlle, Yilmaz, Zehra, Suain, Valérie, De Decker, Robert, Authelet, Michèle, Delatour, Benoit, DUYCKAERTS, Charles, Brion, Jean-Pierre, Potier, Marie-Claude
Published in Frontiers in neuroscience (2018)
Published in Frontiers in neuroscience (2018)
Get full text
Journal Article